Australia's first locally made COVID-19 mRNA vaccine candidate is set for clinical trials

 

The first clinical trials are expected to involve around 150 people, the Victorian government says

He said his team believed this approach was likely to produce a better kind of booster shot for future variants, which could be given to those already vaccinated against the original strain.

The team is also in the early stages of testing an mRNA vaccine candidate modelled on the Kappa variant.

And there's a protein vaccine being trialed as well?

Yes, that's right.

While Monash University has developed an mRNA vaccine candidate, the Doherty Institute has developed a protein vaccine candidate.

Both of them are focused on the receptor-binding domain of the Beta strain, so Professor Pouton said it made sense to work together and run the Phase 1 trial side by side.

The hope is, we'll learn more about whether the approach of targeting the receptor-binding domain is going to be useful to prepare us against future variations.

Full Story Here....

 The Only Safe way out is Vaccination - Do it Today.